Aquestive Therapeutics (AQST) Reports Q2 Loss, Lags Revenue Estimates

Aquestive Therapeutics (AQST) came out with a quarterly loss of $0.14 per share versus the Zacks Consensus Estimate of a loss of$ 0.18. This compares to a loss of $0.03 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of +22.22%. A quarter ago, it was expected that this specialty pharmaceutical company would post a loss of$ 0.17 per share when it actually produced a loss of $0.24, delivering a surprise of -41.18%.Over the last fou ...